The data as presented indicate that four hours after salbutamol was given the FEV, had returned to the presalbutamol level in both the placebo and the nifedipine groups, indicating no enhancement of salbutamol response. The data suggest that nifedipine had an effect of its own, which at 30 minutes failed to be significant at the 5 % level but achieved significance at four and a half hours.
For the authors to make their conclusion additional data are required showing that for their subjects nifedipine did not have a prolonged action of its own in the absence of exposure to salbutamol. This step was not included in the design of the study. Without this evidence their conclusion is unfounded and should be withdrawn. SIR,-Dr Freedman points out in his letter that one of the reasons why we observed the difference between terfenadine and astemizole in our recent comparative trial of these two histamine H,-antagonists for hay fever was that the dose of terfenadine chosen for the comparison was too low. Clearly, this remains a possibility but in designing the trial we naturally chose the oral dose of terfenadine which was the maximum recommended for the treatment of allergic rhinitis. If practitioners are given a recommended dose by manufacturers then it is only reasonable that these dosages are chosen for initial clinical trial work. Clearly, the lack of efficacy demonstrated for terfenadine in our trial would make it worth trying a higher dose in a further comparative study. Nevertheless, I should point out that astemizole offers some advantages over terfenadine in that it is a once daily medication, which on account of its long duration of action, lack of side effects, and Hi antihistaminic potency makes it an ideal drug for the prophylaxis of hay fever. On the other hand, terfenadine with its shorter action may be more profitably used as required for the symptomatic treatment of hay fever symptoms 'rather than in long term prophylaxis. It should also be pointed out that both drugs are relatively ineffective against nasal obstruction in hay fever, and where this is a dominant symptom alternative treatment should be sought with nasal decongestants or local steroids.
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